Chapter 4725-15 Pharmacology

4725-15-01 Required course of study in pharmacology.

The board will recognize candidates as qualified to take the pharmacology examination in accordance with the following:

(A) All applicants for the pharmacology examination must document to the board successful completion of at least fifty-seven clock hours of study in general and ocular pharmacology. That study shall include the nature of adverse reactions caused by topical ocular pharmaceutical agents and emergency steps to be taken in such cases, signs and symptoms of ocular disease, ocular signs and symptoms of systemic disease, appropriate criteria for referrals to physicians, and cardiopulmonary resuscitation.

(B) All of the hours of study required as a prerequisite to the pharmacology examination must have been completed at an institution accredited by a regional or professional accreditation organization that is recognized or approved by the council on postsecondary accreditation" or the United States department of education or its successor. Candidates must document this requirement by submitting a valid certificate of completion of the study

R.C. 119.032 review dates: 05/20/2008 and 05/19/2013

Promulgated Under: 119.03

Statutory Authority: 4725.09

Rule Amplifies: 4725.09 , 4725.12

Prior Effective Dates: 6/25/84, 6/1/99

4725-15-03 Continuing education in pharmacology. [Rescinded].

Rescinded eff 7-28-08

4725-15-04 Board approval of pharmacology and ocular disease continuing education course is as follows.

(A) The board will approve for optometric pharmacology continuing education compliance only those programs which relate to:

(1) General and ocular pharmacology

(2) Signs and symptoms of ocular disease

(3) The diagnosis, treatment and management of ocular disease

(4) Appropriate criteria for referring patients to physicians and co-managing patients with physicians

(5) The use of those instruments which are utilized in conjunction with the topical ocular pharmaceutical agents and therapeutic pharmaceutical agents approved pursuant to section 4725.01 of the Revised Code.

(B) Speakers, lecturers and others participating in the presentation of the programs must be recognized by the board as possessing requisite qualifications and being expert and of recognized repute in their area of instruction.

(C) The course content must reflect that it is comparable to those courses in pharmacology required by optometry boards of other states whose licensees are permitted the use of topical ocular pharmaceutical agents and therapeutic pharmaceutical agents in the course of their practice of optometry.

(D) Programs must be available to all Ohio optometrists. Limitations may be necessary based on space, time or format of presentation and must be so noted on application. Any program that is too restrictive may be denied approval.

(E) Programs must contribute to the advancement of professional skill and knowledge of the participants and enable them to render continuously better and more comprehensive optometric service to the recipients of their care. Programs cannot be used to market the sponsor's/presenter's products or services.

Effective: 07/28/2008
R.C. 119.032 review dates: 05/13/2008 and 07/28/2013
Promulgated Under: 119.03
Statutory Authority: 4725.09
Rule Amplifies: 4725.09 , 4725.16
Prior Effective Dates: 6/25/84, 4/17/95, 6/1/99

4725-15-05 Certificate of course completion; application for approval for pharmacology continuing education courses. [Rescinded].

Rescinded eff 7-28-08

4725-15-06 Fees for renewal and reinstatement of a therapeutic pharmaceutical agents certificate or a certificate to administer topical ocular pharmaceutical agents.

The annual fee to renew or reinstate a therapeutic pharmaceutical agents certificate or a certificate to administer topical ocular pharmaceutical agents shall be twenty-five dollars.

The fee shall be paid along with and in addition to, the annual license renewal fee required in section 4725.34 of the Revised Code.

R.C. 119.032 review dates: 05/20/2008 and 05/19/2013

Promulgated Under: 119.03

Statutory Authority: 4725.09

Rule Amplifies: 4725.09 , 4725.12

Prior Effective Dates: 6/25/84, 6/1/99